Aragon Pharmaceuticals
Aragon Pharmaceuticals has not claimed their Profile.
Want to better differentiate Aragon Pharmaceuticals between your competitors? Show buyers how.
Why does Aragon Pharmaceuticals win vs. Tetraphase Pharmaceuticals?
Show Aragon Pharmaceuticals's primary competitive advantage Show Aragon Pharmaceuticals's competitive differentiationAragon Pharmaceuticals's alternatives and competitors
See how Aragon Pharmaceuticals compares to similar products. Aragon Pharmaceuticals's top competitors include Tetraphase Pharmaceuticals, Biovertis, and Acetylon Pharmaceuticals.
Tetraphase Pharmaceuticals discovers and develops new tetracycline antibiotics to treat drug-resistant bacterial infections using technology developed by Dr. Andrew Mye…
Aragon Pharmaceuticals vs. Tetraphase Pharmaceuticals
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Biovertis discovers and develops antibiotics to combat the increasing threat of infective microbes that are resistant to available therapies.
Aragon Pharmaceuticals vs. Biovertis
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Acetylon Pharmaceuticals is a provider in the development of small molecule drugs targeting epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer …
Aragon Pharmaceuticals vs. Acetylon Pharmaceuticals
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Syndax is a clinical stage biopharmaceutical company developing entinostat as a combination therapy in multiple cancer indications with an initial focus on tumors that …
Aragon Pharmaceuticals vs. Syndax Pharmaceuticals
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Auspex Pharmaceuticals is a privately held biopharmaceutical company focused on the use of deuterium in medicinal chemistry, and the treatment of hyperkinetic movement …
Aragon Pharmaceuticals vs. Auspex Pharmaceuticals
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Marinus Pharmaceuticals is a privately held specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of ganaxolone to treat s…
Aragon Pharmaceuticals vs. Marinus Pharmaceuticals
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Celera Genomics is one of three business segments of Applera Corporation. Celera Genomic's mission is to discover and develop meaningful new therapies that improve huma…
Aragon Pharmaceuticals vs. Celera Genomics
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Calistoga Pharmaceuticals is a biopharmaceutical company developing multiple compounds selectively targeting the PI3K pathway, a pathway known to be involved in certain…
Aragon Pharmaceuticals vs. Calistoga Pharmaceuticals
View more in-depth data on:
- Competitors
- Products
- Customer References and more
CyDex Pharmaceuticals develops drugs specifically designed to address limitations of current therapies for conditions such as bipolar disorder, schizophrenia, fungus, a…
Aragon Pharmaceuticals vs. CyDex Pharmaceuticals
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Cylene Pharmaceuticals is a clinical-stage, private company developing small molecule drugs against newly validated cancer targets. Cylene has taken a position in the d…
Aragon Pharmaceuticals vs. Cylene Pharmaceuticals
View more in-depth data on:
- Competitors
- Products
- Customer References and more
- TE
Terapio is a biopharmaceutical company specializing in the development of a pipeline of therapies based on the transport protein, RLIP76.
Aragon Pharmaceuticals vs. Terapio
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Adipogen is developing drugs to treat obesity based on discoveries from the University of Queensland.
Aragon Pharmaceuticals vs. Adipogen Pharmaceuticals
View more in-depth data on:
- Competitors
- Products
- Customer References and more
- AV
Avalon discovers and develops drugs for various cancers.
Aragon Pharmaceuticals vs. Avalon
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Y's Therapeutics focuses on developing monoclonal antibody therapies and other molecular-targeted biological drugs for the treatment of inflammation-mediated diseases, …
Aragon Pharmaceuticals vs. Y's Therapeutics
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Azides Pharmaceuticals, Inc is a developer of HIV drugs to treat viral strains resistant to existing medications such as azidothymidine, or AZT,
Aragon Pharmaceuticals vs. Azides Pharmaceuticals
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Top 10 Aragon Pharmaceuticals competitors
You May Also Like
Can-Fite BioPharma is a biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities.
Metronome Therapeutics is developing oncology drugs
AnaMar Medical is a company in the field of cartilage biology and associated joint diseases. The company has an project portfolio with five drugs and one biomarker in development and two biomarkers on the market.
Inimex Pharmaceuticals, Inc. is focused on the development and commercialization of Innate Defense Regulators (IDRs), first in class drugs that selectively trigger the body's innate defenses without causing inflammation. IDR products have major market potential for infectious disease, cancer, and inflammatory disease. These products will reduce morbidity and mortality in the rapidly growing population of immune suppressed and elderly patients who are "at-risk" for these disorders. IDR products will also benefit healthcare payors by reducing costs associated with hospitalization. Inimex' lead IDR product IMX942 targets a broad spectrum of life-threatening hospital infections, many of which are caused by antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant Enterococcus (VRE). IMX942 is active against both normal and drug-resistant bacteria and its ability to stimulate host innate immune defenses is not susceptible to bacterial antibiotic resistance mechanisms. The first clinical indication for IMX942 will be the prevention of infections associated with cancer chemotherapy-induced immune suppression. nnAdditional IDR product candidates will be developed for distinct disease areas, with an emphasis on inflammatory disease and demonstration of the potential for orally available IDR dosage forms.
Locus Pharmaceuticals is a privately held pharmaceutical company focused on developing small molecule therapeutic drugs to address unmet medical needs. The company's core technology is a fragment-based, computational approach, which Locus has combinated with highly integrated medicinal chemistry, crystallography and biology capabilities to create a unique drug design and development platform.
MuriGen is building a portfolio of drugs for unmet medical needs across a number of therapeutic areas including cancer, arthritis, thrombocytopenia, inflammation, epilepsy and thalassemia.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.